| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.6B | $9.6B | $8.1B | $6.3B | $4.4B | $1.4B | — | $0.9B |
| Cost of Revenue | $4.3B | $4.0B | $3.6B | $2.6B | $1.9B | $0.6B | $0.5B | — |
| Gross Profit | $6.3B | $5.6B | $4.5B | $3.6B | $2.5B | $0.8B | $0.7B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.8B | $3.4B | $2.8B | $2.2B | $1.6B | $0.4B | $0.3B | $0.3B |
| Operating Income | $2.5B | $2.1B | $1.3B | $1.3B | $0.8B | $0.4B | $0.3B | $0.3B |
| Net Income | $1.8B | $1.6B | $0.9B | $1.0B | $0.6B | $0.3B | $0.2B | $0.1B |
| EPS (Basic) | $14.67 | $12.23 | $6.70 | $7.52 | $4.52 | $2.29 | $1.66 | $0.88 |
| EPS (Diluted) | $14.64 | $12.20 | $6.68 | $7.49 | $4.50 | $2.28 | $1.65 | $0.88 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.6B | $7.1B | $5.6B | $4.9B | $4.2B | $3.3B | $2.1B | $2.0B |
| Current Assets | $4.0B | $4.1B | $3.2B | $2.6B | $2.1B | $1.8B | $1.4B | $1.4B |
| Cash & Equivalents | — | — | — | — | — | — | $0.9B | $1.0B |
| Total Liabilities | $3.3B | $2.9B | $2.5B | $2.2B | $1.6B | $1.3B | $0.6B | $0.4B |
| Current Liabilities | $1.8B | $1.6B | $1.5B | $1.4B | $0.9B | $0.6B | $0.5B | $0.3B |
| Stockholders' Equity | $4.3B | $4.2B | $3.1B | $2.7B | $2.6B | $2.0B | $1.4B | $1.6B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $2.3B | $1.0B | $1.4B | $0.8B | $0.7B | $0.7B | $0.5B |
| Investing Cash Flow | $-0.8B | $-0.7B | $-0.6B | $-0.4B | $-0.7B | $-0.3B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.7B | $0.7B | $0.6B | $0.4B | $0.2B | $0.3B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.7B | $-0.5B | $-0.5B | $-0.8B | $-0.1B | $-0.2B | $-0.6B | $-0.1B |